Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 863

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 863
---
ainer fees, which will be exchanged for shares of New Semnur Common Stock upon closing of the Business Combination pursuant to the terms of the Merger Agreement.

Consulting Services Agreement with Wise Orient Investments Limited, as amended

On July 22, 2025, the Company entered into an amendment to the consulting services agreement previously entered with Wise Orient Investments Limited on August 26, 2024. Pursuant to the amendment, among other things, the parties agreed that in exchange for the services provided thereunder, Wise Orient Investments Limited is issued 3,200,000 shares of Semnur Common Stock as finder and advisory retainer fees, which will be exchanged for shares of New Semnur Common Stock upon closing of the Business Combination pursuant to the terms of the Merger Agreement.

Advisory Services Agreement with JW Investment Management Company Limited, as amended

On June 15, 2025 the Company entered into an advisory services agreement, as amended on July 22, 2025, with JW Investment Management Company Limited (“JW”), pursuant to which JW agreed to perform certain consulting and advisory services related to the Company’s business, financing, and mergers and acquisitions opportunities for a period of 12 months from the date of the agreement. In exchange for the services provided, JW is issued 8,000,000 shares of Semnur Common Stock as finder and advisory retainer fees, which will be exchanged for shares of New Semnur Common Stock upon closing of the Business Combination pursuant to the terms of the Merger Agreement.

Stock Issuance Agreement

On July 22, 2025, Company entered into a stock issuance agreement with the law firm named therein, pursuant to which the law firm is issued 10,000,000 shares of the Semnur Common Stock as a retainer for legal services and payment for prior services, which will be exchanged for shares of New Semnur Common Stock upon closing of the Business Combination pursuant to the terms of the Merger Agreement.**

<div align='center'>F-99</div>

#### Annex A-1

### AGREEMENT AND PLAN OF MERGER

#### dated as of August 30, 2024

#### by and among

#### Denali Capital Acquisition Corp.,

#### Denali Merger Sub Inc.,

#### and

#### Semnur Pharmaceuticals, Inc.
TABLE OF CONTENTS

|                                                         |     |                                                                      |     | Page   |
| ARTICLE I DEFINITIONS                                   |     |                                                                      |     | A-1